Stocktoria
Nuwellis, Inc. NUWE
Nuwellis, Inc. (NUWE) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $8.3M at a -211.9% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| NUWE | Nuwellis, Inc. | 2/9 | — | — | — |
| NRXS | Neuraxis, INC | 3/9 | — | — | — |
| CV | CapsoVision, Inc | 2/9 | — | — | +15.3% |
| HYPR | Hyperfine, Inc. | 4/9 | -16.31 | — | +5.2% |
| HCIL | Hongchang International Co., Ltd | 2/9 | 2.23 | — | — |
| GTHP | GUIDED THERAPEUTICS INC | 3/9 | — | — | — |
| ITOC | iTonic Holdings Ltd | 1/9 | 5.57 | — | — |
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
FAQ
Is NUWE financially healthy?
Nuwellis, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does NUWE pay a dividend?
No, Nuwellis, Inc. does not currently pay a dividend.
How profitable is NUWE?
In FY2025, Nuwellis, Inc. had a net margin of -211.9% and a return on equity of -667.7%.
Is NUWE a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Nuwellis, Inc.: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.